Clinical Trials Browser

Has results × Neoplasm Metastasis × Capecitabine × Clear all

Breast Neoplasms, Neoplasm Metastasis

Breast Neoplasms, Neoplasm Metastasis

Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms

Adenocarcinoma, Gastrointestinal Neoplasms, Neoplasm Metastasis

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Neoplasm Metastasis, Colorectal Neoplasms

Carcinoma, Squamous Cell, Neoplasm Metastasis, Skin Neoplasms

Neoplasm Metastasis, Neoplasms

Neoplasm Metastasis

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Neoplasm Metastasis, Rectal Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Breast Neoplasms, Neoplasm Metastasis

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Breast Neoplasms, Neoplasm Metastasis

Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Adenocarcinoma, Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Clinical Trials

A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer

Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

TASCO1

HIGH-LIGHT

METEORA-II

OBELICS

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors

Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study

BOLERO-6

Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

SorCape

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

X-TRAP

Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model

XAGastric

A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer